Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Suctioning the Nasopharyngeal Airway01:29

Suctioning the Nasopharyngeal Airway

3.2K
Nasopharyngeal suctioning is a procedure to remove secretions from the upper part of the respiratory tract that the patient cannot clear independently. It helps maintain airway patency and prevents complications such as aspiration pneumonia.
Equipment Required
3.2K
Chromatin Position Affects Gene Expression02:35

Chromatin Position Affects Gene Expression

24.7K
Chromatin is the massive complex of DNA and proteins packaged inside the nucleus. The complexity of chromatin folding and how it is packaged inside the nucleus greatly influences  access to genetic information. Generally, the nucleus' periphery is considered transcriptionally repressive, while the cell's interior is considered a transcriptionally active area. 
Topologically Associated Domains (TADs)
The 3-dimensional positioning of chromatin in the nucleus influences the...
24.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Standardization of objectives and response criteria for neoadjuvant immunotherapy in resectable squamous cell carcinoma of the head and neck.

Cancer treatment reviews·2026
Same author

A multicentre phase 2 study of trifluridine/tipiracil in recurrent/metastatic platinum resistant nasopharyngeal carcinomas.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

Distribution of Immune Cells in Tumor Microenvironment Correlates With Checkpoint Inhibitor Response in Nasopharyngeal Carcinoma: A Multiregional Study.

JCO global oncology·2026
Same author

Analysis of Plasma Epstein-Barr Virus DNA and Clinical Outcomes to Pembrolizumab or Chemotherapy in Recurrent/Metastatic Nasopharyngeal Cancer in KEYNOTE-122.

Cancer medicine·2026
Same author

The arrival of antibody drug conjugates in nasopharyngeal cancer.

Lancet (London, England)·2025
Same author

Achieving control of nasopharyngeal carcinoma: the role of Epstein-Barr virus-based screening and vaccines.

Nature reviews. Clinical oncology·2025

Related Experiment Video

Updated: Jan 23, 2026

Coculture System with an Organotypic Brain Slice and 3D Spheroid of Carcinoma Cells
07:48

Coculture System with an Organotypic Brain Slice and 3D Spheroid of Carcinoma Cells

Published on: October 9, 2013

21.3K

Nasopharyngeal carcinoma.

Yu-Pei Chen1, Anthony T C Chan2, Quynh-Thu Le3

  • 1Department of Radiation Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, People's Republic of China.

Lancet (London, England)
|June 11, 2019
PubMed
Summary

Nasopharyngeal carcinoma incidence and mortality are declining due to improved understanding, screening with plasma Epstein-Barr virus (EBV) DNA, and advanced treatments like intensity-modulated radiotherapy and immunotherapy.

More Related Videos

A "Patient-Like" Orthotopic Syngeneic Mouse Model of Hepatocellular Carcinoma Metastasis
05:06

A "Patient-Like" Orthotopic Syngeneic Mouse Model of Hepatocellular Carcinoma Metastasis

Published on: October 24, 2015

12.8K
Multidimensional Coculture System to Model Lung Squamous Carcinoma Progression
07:53

Multidimensional Coculture System to Model Lung Squamous Carcinoma Progression

Published on: March 17, 2020

7.7K

Related Experiment Videos

Last Updated: Jan 23, 2026

Coculture System with an Organotypic Brain Slice and 3D Spheroid of Carcinoma Cells
07:48

Coculture System with an Organotypic Brain Slice and 3D Spheroid of Carcinoma Cells

Published on: October 9, 2013

21.3K
A "Patient-Like" Orthotopic Syngeneic Mouse Model of Hepatocellular Carcinoma Metastasis
05:06

A "Patient-Like" Orthotopic Syngeneic Mouse Model of Hepatocellular Carcinoma Metastasis

Published on: October 24, 2015

12.8K
Multidimensional Coculture System to Model Lung Squamous Carcinoma Progression
07:53

Multidimensional Coculture System to Model Lung Squamous Carcinoma Progression

Published on: March 17, 2020

7.7K

Area of Science:

  • Oncology
  • Epidemiology
  • Virology

Background:

  • Nasopharyngeal carcinoma (NPC) shows distinct geographical prevalence, particularly in East and Southeast Asia.
  • Recent epidemiological trends indicate a gradual decline in NPC incidence and substantial reduction in mortality.
  • These changes are attributed to evolving lifestyles, environmental factors, and improved understanding of NPC pathogenesis.

Purpose of the Study:

  • To review recent advancements in nasopharyngeal carcinoma management.
  • To highlight the role of plasma Epstein-Barr virus (EBV) DNA in screening and monitoring.
  • To discuss the impact of modern radiotherapy and chemotherapy on patient outcomes.

Main Methods:

  • Review of epidemiological trends and clinical outcomes in nasopharyngeal carcinoma.
  • Analysis of the application of plasma Epstein-Barr virus (EBV) DNA for screening and prognostication.
  • Evaluation of intensity-modulated radiotherapy and optimized chemotherapy strategies.
  • Assessment of novel therapeutics, including immune checkpoint inhibitors.

Main Results:

  • Significant reductions in nasopharyngeal carcinoma incidence and mortality observed over the past decade.
  • Plasma Epstein-Barr virus (EBV) DNA proves effective for population screening, prognostication, and surveillance.
  • Intensity-modulated radiotherapy and optimized chemotherapy regimens have improved survival and reduced toxicity.
  • Immune checkpoint therapies show promise for recurrent or metastatic nasopharyngeal carcinoma.

Conclusions:

  • Advancements in understanding, screening, and treatment have led to improved nasopharyngeal carcinoma outcomes.
  • Plasma Epstein-Barr virus (EBV) DNA is a valuable tool in the multidisciplinary management of nasopharyngeal carcinoma.
  • Novel therapeutics, particularly immune checkpoint inhibitors, offer a promising future for advanced nasopharyngeal carcinoma.